ProfileGDS4132 / 209169_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 33% 31% 38% 32% 37% 33% 35% 41% 35% 31% 27% 28% 32% 29% 31% 24% 33% 41% 30% 24% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10181.560833
GSM201543Muscle PCOS pioglitazone 12167.546631
GSM201544Muscle PCOS pioglitazone 16198.142938
GSM201545Muscle PCOS pioglitazone 20188.896732
GSM201829Muscle PCOS pioglitazone 23199.610837
GSM201830Muscle PCOS pioglitazon 25184.810233
GSM201831Muscle PCOS pioglitazone 27186.844435
GSM201832Muscle PCOS pioglitazone 31106.09741
GSM201833Muscle PCOS pioglitazone 4183.052235
GSM201834Muscle PCOS pioglitazone 8175.4531
GSM201835Muscle PCOS after pioglitazone 10253.05227
GSM201836Muscle PCOS after pioglitazone 12256.538528
GSM201837Muscle PCOS after pioglitazone 16264.795732
GSM201838Muscle PCOS after pioglitazone 20263.506429
GSM201839Muscle PCOS after pioglitazone 23271.351131
GSM201840Muscle PCOS after pioglitazone 25254.667724
GSM201841Muscle PCOS after pioglitazone 27267.142233
GSM201842Muscle PCOS after pioglitazone 3286.772641
GSM201843Muscle PCOS after pioglitazone 4272.853330
GSM201844Muscle PCOS after pioglitazone 8252.350224